Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Benzimidazole-1,3,4-Oxadiazol-2-N-Alkyl/Aryl Amines-Reference-Cited by-同舟云学术

Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Benzimidazole-1,3,4-Oxadiazol-2-N-Alkyl/Aryl Amines

Published:2021-08-02 Issue: Volume: Page:1-15
ISSN:1040-6638
Container-title:Polycyclic Aromatic Compounds
language:en
Short-container-title:Polycyclic Aromatic Compounds

Author:

Katikireddy Ramamurthy¹²,Marri Srinivas¹³^ORCID,Kakkerla Ramu⁴,Murali Krishna M. P. S.⁵,Gandamalla Durgaiah⁶^ORCID,Reddy Y. N.⁶

Affiliation:

1. Department of Chemistry, JNTUK, Kakinada, Andhra Pradesh, India

2. JN Pharmacity, Enantilabs Pvt. Ltd, Visakhapatnam, Andhra Pradesh, India

3. Department of Chemistry, Siddhartha Degree and P.G. College, Narsampet, Telangana State, India

4. Department of Chemistry, Satavahana University, Karimnagar, Telangana State, India

5. Department of Chemistry, Andhra Polytechnic College, Kakinada, Andhra Pradesh, India

6. Department of Pharmacology and Toxicology, Kakatiya University, Warangal, Telangana State, India

Publisher

Informa UK Limited

Subject

Materials Chemistry,Organic Chemistry,Polymers and Plastics

Link

https://www.tandfonline.com/doi/pdf/10.1080/10406638.2021.1959352

Reference50 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2. Cancer incidence and mortality worldwide, Lyon. International Agency for Research on Cancer (2011). (IARC Cancer Base No. 10).

3. Cancer is a Preventable Disease that Requires Major Lifestyle Changes

4. Global Cancer Observatory, International Agency for Research on Cancer, WHO ( 2018) Cancer today – Data visualization tools for exploring the global cancer burden in 2018.

5. Improving the evaluation of new cancer treatments: challenges and opportunities

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship;Bioorganic Chemistry;2023-09

2. Synthesis and cytotoxic activity evaluation of novel dihydroartemisinin and zerumbone conjugates with 2-mercapto-1,3,4-oxadiazoles as potential EGFR inhibitors;Journal of Chemical Research;2023-09

3. A Comprehensive Review on the Benzimidazole Scaffold as a Potential Nucleus for Anticancer Activity;Letters in Organic Chemistry;2023-09

4. The medicinal panorama of benzimidazoles and their scaffolds as anticancer and antithrombotic agents: A review;Archiv der Pharmazie;2023-07-13

5. New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents;Archiv der Pharmazie;2022-11-09